APO Research
Talk to an analyst

APO RESEARCH · REPORT

L-(+)-Ergothioneine

L (+) Ergothioneine is a naturally occurring sulfur containing derivative of L histidine with the molecular formula C9H15N3O2S and a molecular mass of 229.30 g/mol.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

L (+) Ergothioneine is a naturally occurring sulfur containing derivative of L histidine with the molecular formula C9H15N3O2S and a molecular mass of 229.30 g/mol. Its molecular structure contains a trimethylated histidine backbone and a sulfur substituted imidazole ring, forming an amino acid betaine with a permanent zwitterionic character. The molecule exists in equilibrium between thiol and thione tautomers. At physiological pH the thione form predominates, which substantially limits spontaneous oxidation and gives ergothioneine greater chemical stability than many conventional low molecular weight thiols. This thione chemistry also permits redox reactions and transition metal coordination while retaining high aqueous solubility. High purity commercial material is typically supplied as a white crystalline powder. The synthetic material assessed by the European Food Safety Authority specifies chemical purity of at least 99.5 percent by HPLC and positive optical rotation consistent with the naturally occurring L configuration.

Natural ergothioneine biosynthesis occurs in selected fungi and bacteria through histidine derived sulfur incorporation pathways. Mushrooms contain particularly high concentrations, while lower concentrations occur in beans, cereals, animal tissues and other foods through biological uptake and food chain transfer. Humans do not possess a known endogenous biosynthetic pathway for ergothioneine and obtain it from dietary sources. Absorption and tissue retention are strongly associated with the SLC22A4 transporter, commonly termed OCTN1 or the ergothioneine transporter, which mediates intestinal uptake, cellular accumulation and renal reabsorption. Ergothioneine can consequently accumulate in erythrocytes and several tissues despite relatively low dietary concentrations. Its thione dominated chemistry gives the molecule resistance to autoxidation and enables reactions with reactive oxygen and nitrogen species and coordination with selected metal ions. These physicochemical properties underpin its use as a functional ingredient, while its precise physiological roles in humans remain an active area of biochemical research.

Industrial L (+) Ergothioneine is manufactured principally by microbial fermentation, enzyme catalyzed synthesis and chemical synthesis. Commercial fermentation routes use engineered microorganisms carrying ergothioneine biosynthetic enzymes, with current FDA GRAS records documenting production using engineered Escherichia coli strains. Chemical production has also been established commercially and was the manufacturing basis of the synthetic material evaluated by EFSA. Enzyme catalyzed routes convert histidine derived precursors through selective sulfur incorporation reactions and are currently used by commercial ingredient manufacturers. These technologies produce chemically equivalent L ergothioneine when stereochemical configuration, molecular identity, purity and impurity specifications are controlled. Commercial material is used in dietary supplements, foods and beverages, cosmetics and personal care formulations, with food use subject to jurisdiction specific regulatory requirements. The European Union currently lists L ergothioneine as an authorised novel food for specified food categories and food supplements.

The research object may be an ingredient, device, preparation or care service. These supply stages have different specifications and measurement units; an ingredient identity or device name does not establish a clinical outcome.

What turns activity into demand

Qualified use at the specified treatment or instrument boundary creates purchases through protocol, utilisation and replacement. A product, clinical service and complete care episode measure different supplied objects.

The commercial boundary

For L-(+)-Ergothioneine, distinguish the supplied product from its inputs and the complete application. Report types and applications may overlap; retain the selected edition's product definition, geography, period, unit and transaction basis when comparing estimates.

Which conditions determine usable l-(+)-ergothioneine performance?

L (+) Ergothioneine is a naturally occurring sulfur containing derivative of L histidine with the molecular formula C9H15N3O2S and a molecular mass of 229.30 g/mol. Confirm the specified composition or device function, intended use and supplied unit. Separate ingredients, finished preparations, equipment and treatment activity before comparing quantities or revenue; use the report scope rather than inferring efficacy from an illustration.

Selected research

Industry Growth & Trends

Global L-(+)-Ergothioneine Industry Growth and Trends Forecast to 2032

6 September 2026113 pages

Choose your research edition.

Industry ResearchL-(+)-Ergothioneine Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal L-(+)-Ergothioneine Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal L-(+)-Ergothioneine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal L-(+)-Ergothioneine Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal L-(+)-Ergothioneine Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

According to APO Research, Inc, the global L (+) Ergothioneine market was valued at USD 68.53 million in 2025 and is expected to reach USD 84.17 million in 2026 and USD 191.86 million by 2032, representing a CAGR of 14.72% from 2026 to 2032. Global sales volume is estimated at 25.86 t in 2025 and 33.40 t in 2026, reaching 107.79 t in 2032, equivalent to a volume CAGR of 21.56%. The weighted ex factory net price is estimated at USD 2,650.00 per kg in 2025, USD 2,520.00 per kg in 2026 and USD 1,780.00 per kg in 2032, corresponding to an average annual price decline of 5.63% during 2026 to 2032. Effective manufacturing capacity is estimated at 72.50 t in 2025, 92.01 t in 2026 and 189.97 t in 2032, while utilization increases from 35.67% to 36.30% and 56.74%, respectively. The value expansion therefore comes primarily from higher physical consumption, rising utilization and broader downstream formulation volumes as fermentation productivity and purification economics reduce unit cost.

China is expected to contribute the largest manufacturing increment through GeneIII Biotechnology, Chuanning Biotechnology, Shanghai EGT Synbio, Readline Biotech, SIYOMICRO, Bloomage Biotech, Abiochem and other commercial producers. GeneIII reports monthly L (+) Ergothioneine capacity of 3.00 to 5.00 t, equivalent to 36.00 to 60.00 t on an annualized basis, with product purity reaching 99.99%. This disclosed capacity alone exceeds the audited 2026 global sales volume of 33.40 t and provides a direct physical explanation for the relatively low industry utilization rate. SIYOMICRO has reported stable production scale up in a 100.00 t fermenter, while Readline has commissioned two hundred tonne class shared active ingredient production lines in Zhuhai with commercial scale production of ergothioneine. Chuanning exceeded its 11.00 g/L fermentation titer objective and annual production target in 2025. Bloomage commercially produces MitoEGT through one step biosynthesis, and Shanghai EGT Synbio has established commercial biological production of Dr.Ergo. The current FDA GRAS inventory contains four ergothioneine notices. Blue California, Shanghai EGT Synbio and GeneIII have received FDA no questions letters. Abiochem remains under review.

Fermentation is expected to account for the largest incremental production volume through 2032 as strain productivity, fermentation titer, reactor scale, downstream recovery and crystallization yield improve. Enzymatic synthesis and chemical synthesis remain relevant for selected manufacturing configurations and purity specifications. Dietary supplements are expected to remain the largest application by value, followed by food and beverages and cosmetics and personal care, with pet nutrition representing a smaller commercial application. Regulatory inclusion levels provide a useful physical demand anchor. The European Union permits up to 30.00 mg per day in food supplements for the general population, 25.00 mg per kg in alcohol free beverages and milk based drinks, 40.00 mg per kg in fresh milk products, 200.00 mg per kg in cereal bars and 250.00 mg per kg in chocolate confectionery. At 30.00 mg per day, 1.00 t of L (+) Ergothioneine corresponds to approximately 33.33 million supplement consumption days. At 25.00 mg per kg, 1.00 t can theoretically supply 40,000.00 t of beverage at the permitted maximum inclusion level. These low unit dosages allow large downstream finished product volumes to absorb relatively modest ingredient tonnage, while continued price reductions materially enlarge the addressable formulation base. Commercial demand is recurrent because L (+) Ergothioneine is consumed within finished formulations and replenished with continuing supplement, food, beverage, cosmetic and pet nutrition production.

Read the full market overview

Report Scope

This report provides a structured, data-driven view of the global L-(+)-Ergothioneine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The L-(+)-Ergothioneine market size, estimates, and forecasts are presented in terms of sales volume (kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global L-(+)-Ergothioneine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to L-(+)-Ergothioneine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global L-(+)-Ergothioneine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

L-(+)-Ergothioneine Market by Company

Bloomage Biotech

Chuanning Biotechnology

Shanghai EGT Synbio

GeneIII Biotechnology

Readline Biotech

SIYOMICRO

Abiochem

Magic Health

Seedling Bio

Focusfreda

Nutri Force

Natural Field

GsynBio

Hechen Bioworkx

Changzhou Kaixing Biotechnology

Spec Chem Industry

Conagen

Mironova Labs

NAGASE

L-(+)-Ergothioneine Segment by Type

Fermentation

Enzymatic Synthesis

Chemical Synthesis

L-(+)-Ergothioneine Segment by Application

Dietary Supplements

Food & Beverages

Cosmetics & Personal Care

Pet Nutrition

L-(+)-Ergothioneine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global L-(+)-Ergothioneine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of L-(+)-Ergothioneine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of L-(+)-Ergothioneine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of L-(+)-Ergothioneine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of L-(+)-Ergothioneine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Fermentation Table 2. Major Company of Enzymatic Synthesis Table 3. Major Company of Chemical Synthesis Table 4. Global L-(+)-Ergothioneine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global L-(+)-Ergothioneine Sales by Type (2021-2026) & (kg) Table 6. Global L-(+)-Ergothioneine Sales Market Share in Volume by Type (2021-2026) Table 7. Global L-(+)-Ergothioneine Sales by Type (2021-2026) & (US$ Million) Table 8. Global L-(+)-Ergothioneine Sales Market Share in Value by Type (2021-2026) Table 9. Global L-(+)-Ergothioneine Price by Type (2021-2026) & (USD/kg) Table 10. Global L-(+)-Ergothioneine Sales by Type (2027-2032) & (kg) Table 11. Global L-(+)-Ergothioneine Sales Market Share in Volume by Type (2027-2032) Table 12. Global L-(+)-Ergothioneine Sales by Type (2027-2032) & (US$ Million) Table 13. Global L-(+)-Ergothioneine Sales Market Share in Value by Type (2027-2032) Table 14. Global L-(+)-Ergothioneine Price by Type (2027-2032) & (USD/kg) Table 15. North America L-(+)-Ergothioneine Sales by Type (2021-2026) & (kg) Table 16. North America L-(+)-Ergothioneine Sales by Type (2021-2026) & (US$ Million) Table 17. Europe L-(+)-Ergothioneine Sales by Type (2021-2026) & (kg) Table 18. Europe L-(+)-Ergothioneine Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific L-(+)-Ergothioneine Sales by Type (2021-2026) & (kg) Table 20. Asia-Pacific L-(+)-Ergothioneine Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America L-(+)-Ergothioneine Sales by Type (2021-2026) & (kg) Table 22. Latin America L-(+)-Ergothioneine Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa L-(+)-Ergothioneine Sales by Type (2021-2026) & (kg) Table 24. Middle East and Africa L-(+)-Ergothioneine Sales by Type (2021-2026) & (US$ Million) Table 25. L-(+)-Ergothioneine Industry Trends Table 26. L-(+)-Ergothioneine Industry Drivers Table 27. L-(+)-Ergothioneine Industry Opportunities and Challenges Table 28. L-(+)-Ergothioneine Industry Restraints Table 29. Global L-(+)-Ergothioneine Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global L-(+)-Ergothioneine Revenue Market Share by Company (2021-2026) Table 31. Global L-(+)-Ergothioneine Sales by Company (2021-2026) & (kg) Table 32. Global L-(+)-Ergothioneine Sales Share by Company (2021-2026) Table 33. Global L-(+)-Ergothioneine Market Price by Company (2021-2026) & (USD/kg) Table 34. Global L-(+)-Ergothioneine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global L-(+)-Ergothioneine Major Company Production Sites and Headquarters Table 36. Global L-(+)-Ergothioneine Company, Product Type & Application Table 37. Global L-(+)-Ergothioneine Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global L-(+)-Ergothioneine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global L-(+)-Ergothioneine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global L-(+)-Ergothioneine Sales by Region (2021-2026) & (kg) Table 42. Global L-(+)-Ergothioneine Sales Market Share in Volume by Region (2021-2026) Table 43. Global L-(+)-Ergothioneine Sales by Region (2021-2026) & (US$ Million) Table 44. Global L-(+)-Ergothioneine Sales Market Share in Value by Region (2021-2026) Table 45. Global L-(+)-Ergothioneine Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 46. Global L-(+)-Ergothioneine Sales by Region (2027-2032) & (kg) Table 47. Global L-(+)-Ergothioneine Sales Market Share in Volume by Region (2027-2032) Table 48. Global L-(+)-Ergothioneine Sales by Region (2027-2032) & (US$ Million) Table 49. Global L-(+)-Ergothioneine Sales Market Share in Value by Region (2027-2032) Table 50. Global L-(+)-Ergothioneine Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2027-2032) Table 51. Global L-(+)-Ergothioneine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global L-(+)-Ergothioneine Sales by Application (2021-2026) & (kg) Table 53. Global L-(+)-Ergothioneine Sales Market Share in Volume by Application (2021-2026) Table 54. Global L-(+)-Ergothioneine Sales by Application (2021-2026) & (US$ Million) Table 55. Global L-(+)-Ergothioneine Sales Market Share in Value by Application (2021-2026) Table 56. Global L-(+)-Ergothioneine Price by Application (2021-2026) & (USD/kg) Table 57. Global L-(+)-Ergothioneine Sales by Application (2027-2032) & (kg) Table 58. Global L-(+)-Ergothioneine Sales Market Share in Volume by Application (2027-2032) Table 59. Global L-(+)-Ergothioneine Sales by Application (2027-2032) & (US$ Million) Table 60. Global L-(+)-Ergothioneine Sales Market Share in Value by Application (2027-2032) Table 61. Global L-(+)-Ergothioneine Price by Application (2027-2032) & (USD/kg) Table 62. North America L-(+)-Ergothioneine Sales by Application (2021-2026) & (kg) Table 63. North America L-(+)-Ergothioneine Sales by Application (2021-2026) & (US$ Million) Table 64. Europe L-(+)-Ergothioneine Sales by Application (2021-2026) & (kg) Table 65. Europe L-(+)-Ergothioneine Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific L-(+)-Ergothioneine Sales by Application (2021-2026) & (kg) Table 67. Asia-Pacific L-(+)-Ergothioneine Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America L-(+)-Ergothioneine Sales by Application (2021-2026) & (kg) Table 69. Latin America L-(+)-Ergothioneine Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa L-(+)-Ergothioneine Sales by Application (2021-2026) & (kg) Table 71. Middle East and Africa L-(+)-Ergothioneine Sales by Application (2021-2026) & (US$ Million) Table 72. Bloomage Biotech Company Information Table 73. Bloomage Biotech Business Overview Table 74. Bloomage Biotech L-(+)-Ergothioneine Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 75. Bloomage Biotech L-(+)-Ergothioneine Product Portfolio Table 76. Bloomage Biotech Recent Development Table 77. Chuanning Biotechnology Company Information Table 78. Chuanning Biotechnology Business Overview Table 79. Chuanning Biotechnology L-(+)-Ergothioneine Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 80. Chuanning Biotechnology L-(+)-Ergothioneine Product Portfolio Table 81. Chuanning Biotechnology Recent Development Table 82. Shanghai EGT Synbio Company Information Table 83. Shanghai EGT Synbio Business Overview Table 84. Shanghai EGT Synbio L-(+)-Ergothioneine Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 85. Shanghai EGT Synbio L-(+)-Ergothioneine Product Portfolio Table 86. Shanghai EGT Synbio Recent Development Table 87. GeneIII Biotechnology Company Information Table 88. GeneIII Biotechnology Business Overview Table 89. GeneIII Biotechnology L-(+)-Ergothioneine Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 90. GeneIII Biotechnology L-(+)-Ergothioneine Product Portfolio Table 91. GeneIII Biotechnology Recent Development Table 92. Readline Biotech Company Information Table 93. Readline Biotech Business Overview Table 94. Readline Biotech L-(+)-Ergothioneine Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 95. Readline Biotech L-(+)-Ergothioneine Product Portfolio Table 96. Readline Biotech Recent Development Table 97. SIYOMICRO Company Information Table 98. SIYOMICRO Business Overview Table 99. SIYOMICRO L-(+)-Ergothioneine Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 100. SIYOMICRO L-(+)-Ergothioneine Product Portfolio Table 101. SIYOMICRO Recent Development Table 102. Abiochem Company Information Table 103. Abiochem Business Overview Table 104. Abiochem L-(+)-Ergothioneine Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 105. Abiochem L-(+)-Ergothioneine Product Portfolio Table 106. Abiochem Recent Development Table 107. Magic Health Company Information Table 108. Magic Health Business Overview Table 109. Magic Health L-(+)-Ergothioneine Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 110. Magic Health L-(+)-Ergothioneine Product Portfolio Table 111. Magic Health Recent Development Table 112. Seedling Bio Company Information Table 113. Seedling Bio Business Overview Table 114. Seedling Bio L-(+)-Ergothioneine Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 115. Seedling Bio L-(+)-Ergothioneine Product Portfolio Table 116. Seedling Bio Recent Development Table 117. Focusfreda Company Information Table 118. Focusfreda Business Overview Table 119. Focusfreda L-(+)-Ergothioneine Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 120. Focusfreda L-(+)-Ergothioneine Product Portfolio Table 121. Focusfreda Recent Development Table 122. Nutri Force Company Information Table 123. Nutri Force Business Overview Table 124. Nutri Force L-(+)-Ergothioneine Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 125. Nutri Force L-(+)-Ergothioneine Product Portfolio Table 126. Nutri Force Recent Development Table 127. Natural Field Company Information Table 128. Natural Field Business Overview Table 129. Natural Field L-(+)-Ergothioneine Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 130. Natural Field L-(+)-Ergothioneine Product Portfolio Table 131. Natural Field Recent Development Table 132. GsynBio Company Information Table 133. GsynBio Business Overview Table 134. GsynBio L-(+)-Ergothioneine Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 135. GsynBio L-(+)-Ergothioneine Product Portfolio Table 136. GsynBio Recent Development Table 137. Hechen Bioworkx Company Information Table 138. Hechen Bioworkx Business Overview Table 139. Hechen Bioworkx L-(+)-Ergothioneine Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 140. Hechen Bioworkx L-(+)-Ergothioneine Product Portfolio Table 141. Hechen Bioworkx Recent Development Table 142. Changzhou Kaixing Biotechnology Company Information Table 143. Changzhou Kaixing Biotechnology Business Overview Table 144. Changzhou Kaixing Biotechnology L-(+)-Ergothioneine Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 145. Changzhou Kaixing Biotechnology L-(+)-Ergothioneine Product Portfolio Table 146. Changzhou Kaixing Biotechnology Recent Development Table 147. Spec Chem Industry Company Information Table 148. Spec Chem Industry Business Overview Table 149. Spec Chem Industry L-(+)-Ergothioneine Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 150. Spec Chem Industry L-(+)-Ergothioneine Product Portfolio Table 151. Spec Chem Industry Recent Development Table 152. Conagen Company Information Table 153. Conagen Business Overview Table 154. Conagen L-(+)-Ergothioneine Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 155. Conagen L-(+)-Ergothioneine Product Portfolio Table 156. Conagen Recent Development Table 157. Mironova Labs Company Information Table 158. Mironova Labs Business Overview Table 159. Mironova Labs L-(+)-Ergothioneine Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 160. Mironova Labs L-(+)-Ergothioneine Product Portfolio Table 161. Mironova Labs Recent Development Table 162. NAGASE Company Information Table 163. NAGASE Business Overview Table 164. NAGASE L-(+)-Ergothioneine Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 165. NAGASE L-(+)-Ergothioneine Product Portfolio Table 166. NAGASE Recent Development Table 167. North America L-(+)-Ergothioneine Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 168. North America L-(+)-Ergothioneine Sales by Country (2021-2026) & (kg) Table 169. North America L-(+)-Ergothioneine Sales Market Share by Country (2021-2026) Table 170. North America L-(+)-Ergothioneine Sales Forecast by Country (2027-2032) & (kg) Table 171. North America L-(+)-Ergothioneine Sales Market Share Forecast by Country (2027-2032) Table 172. North America L-(+)-Ergothioneine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. North America L-(+)-Ergothioneine Market Size by Country (2021-2026) & (US$ Million) Table 174. North America L-(+)-Ergothioneine Market Share by Country (2021-2026) Table 175. North America L-(+)-Ergothioneine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. North America L-(+)-Ergothioneine Market Share Forecast by Country (2027-2032) Table 177. Europe L-(+)-Ergothioneine Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 178. Europe L-(+)-Ergothioneine Sales by Country (2021-2026) & (kg) Table 179. Europe L-(+)-Ergothioneine Sales Market Share by Country (2021-2026) Table 180. Europe L-(+)-Ergothioneine Sales Forecast by Country (2027-2032) & (kg) Table 181. Europe L-(+)-Ergothioneine Sales Market Share Forecast by Country (2027-2032) Table 182. Europe L-(+)-Ergothioneine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. Europe L-(+)-Ergothioneine Market Size by Country (2021-2026) & (US$ Million) Table 184. Europe L-(+)-Ergothioneine Market Share by Country (2021-2026) Table 185. Europe L-(+)-Ergothioneine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. Europe L-(+)-Ergothioneine Market Share Forecast by Country (2027-2032) Table 187. Asia-Pacific L-(+)-Ergothioneine Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 188. Asia-Pacific L-(+)-Ergothioneine Sales by Country (2021-2026) & (kg) Table 189. Asia-Pacific L-(+)-Ergothioneine Sales Market Share by Country (2021-2026) Table 190. Asia-Pacific L-(+)-Ergothioneine Sales Forecast by Country (2027-2032) & (kg) Table 191. Asia-Pacific L-(+)-Ergothioneine Sales Market Share Forecast by Country (2027-2032) Table 192. Asia-Pacific L-(+)-Ergothioneine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 193. Asia-Pacific L-(+)-Ergothioneine Market Size by Country (2021-2026) & (US$ Million) Table 194. Asia-Pacific L-(+)-Ergothioneine Market Share by Country (2021-2026) Table 195. Asia-Pacific L-(+)-Ergothioneine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 196. Asia-Pacific L-(+)-Ergothioneine Market Share Forecast by Country (2027-2032) Table 197. Latin America L-(+)-Ergothioneine Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 198. Latin America L-(+)-Ergothioneine Sales by Country (2021-2026) & (kg) Table 199. Latin America L-(+)-Ergothioneine Sales Market Share by Country (2021-2026) Table 200. Latin America L-(+)-Ergothioneine Sales Forecast by Country (2027-2032) & (kg) Table 201. Latin America L-(+)-Ergothioneine Sales Market Share Forecast by Country (2027-2032) Table 202. Latin America L-(+)-Ergothioneine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 203. Latin America L-(+)-Ergothioneine Market Size by Country (2021-2026) & (US$ Million) Table 204. Latin America L-(+)-Ergothioneine Market Share by Country (2021-2026) Table 205. Latin America L-(+)-Ergothioneine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 206. Latin America L-(+)-Ergothioneine Market Share Forecast by Country (2027-2032) Table 207. Middle East and Africa L-(+)-Ergothioneine Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 208. Middle East and Africa L-(+)-Ergothioneine Sales by Country (2021-2026) & (kg) Table 209. Middle East and Africa L-(+)-Ergothioneine Sales Market Share by Country (2021-2026) Table 210. Middle East and Africa L-(+)-Ergothioneine Sales Forecast by Country (2027-2032) & (kg) Table 211. Middle East and Africa L-(+)-Ergothioneine Sales Market Share Forecast by Country (2027-2032) Table 212. Middle East and Africa L-(+)-Ergothioneine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 213. Middle East and Africa L-(+)-Ergothioneine Market Size by Country (2021-2026) & (US$ Million) Table 214. Middle East and Africa L-(+)-Ergothioneine Market Share by Country (2021-2026) Table 215. Middle East and Africa L-(+)-Ergothioneine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 216. Middle East and Africa L-(+)-Ergothioneine Market Share Forecast by Country (2027-2032) Table 217. Key Raw Materials Table 218. Raw Materials Key Suppliers Table 219. L-(+)-Ergothioneine Distributors List Table 220. L-(+)-Ergothioneine Customers List Table 221. Research Programs/Design for This Report Table 222. Authors List of This Report Table 223. Secondary Sources Table 224. Primary Sources List of Figures Figure 1. L-(+)-Ergothioneine Image Figure 2. Global L-(+)-Ergothioneine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global L-(+)-Ergothioneine Market Size (2021-2032) & (US$ Million) Figure 4. Global L-(+)-Ergothioneine Sales (2021-2032) & (kg) Figure 5. Fermentation Image Figure 6. Global Fermentation Sales YoY Growth (2021-2032) & (kg) Figure 7. Enzymatic Synthesis Image Figure 8. Global Enzymatic Synthesis Sales YoY Growth (2021-2032) & (kg) Figure 9. Chemical Synthesis Image Figure 10. Global Chemical Synthesis Sales YoY Growth (2021-2032) & (kg) Figure 11. Global L-(+)-Ergothioneine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global L-(+)-Ergothioneine Market Share by Type 2025 VS 2032 Figure 13. North America L-(+)-Ergothioneine Sales Market Share in Volume by Type in 2025 Figure 14. North America L-(+)-Ergothioneine Sales Market Share in Value by Type in 2025 Figure 15. Europe L-(+)-Ergothioneine Sales Market Share in Volume by Type in 2025 Figure 16. Europe L-(+)-Ergothioneine Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific L-(+)-Ergothioneine Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific L-(+)-Ergothioneine Sales Market Share in Value by Type in 2025 Figure 19. Latin America L-(+)-Ergothioneine Sales Market Share in Volume by Type in 2025 Figure 20. Latin America L-(+)-Ergothioneine Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa L-(+)-Ergothioneine Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa L-(+)-Ergothioneine Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 L-(+)-Ergothioneine Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Dietary Supplements Image Figure 26. Global Dietary Supplements Sales YoY Growth (2021-2032) & (kg) Figure 27. Food & Beverages Image Figure 28. Global Food & Beverages Sales YoY Growth (2021-2032) & (kg) Figure 29. Cosmetics & Personal Care Image Figure 30. Global Cosmetics & Personal Care Sales YoY Growth (2021-2032) & (kg) Figure 31. Pet Nutrition Image Figure 32. Global Pet Nutrition Sales YoY Growth (2021-2032) & (kg) Figure 33. Global L-(+)-Ergothioneine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global L-(+)-Ergothioneine Market Share by Application 2025 VS 2032 Figure 35. North America L-(+)-Ergothioneine Sales Market Share in Volume by Application in 2025 Figure 36. North America L-(+)-Ergothioneine Sales Market Share in Value by Application in 2025 Figure 37. Europe L-(+)-Ergothioneine Sales Market Share in Volume by Application in 2025 Figure 38. Europe L-(+)-Ergothioneine Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific L-(+)-Ergothioneine Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific L-(+)-Ergothioneine Sales Market Share in Value by Application in 2025 Figure 41. Latin America L-(+)-Ergothioneine Sales Market Share in Volume by Application in 2025 Figure 42. Latin America L-(+)-Ergothioneine Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa L-(+)-Ergothioneine Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa L-(+)-Ergothioneine Sales Market Share in Value by Application in 2025 Figure 45. North America L-(+)-Ergothioneine Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 46. North America L-(+)-Ergothioneine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America L-(+)-Ergothioneine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America L-(+)-Ergothioneine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe L-(+)-Ergothioneine Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 50. Europe L-(+)-Ergothioneine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe L-(+)-Ergothioneine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe L-(+)-Ergothioneine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific L-(+)-Ergothioneine Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 54. Asia-Pacific L-(+)-Ergothioneine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific L-(+)-Ergothioneine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific L-(+)-Ergothioneine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America L-(+)-Ergothioneine Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 58. Latin America L-(+)-Ergothioneine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America L-(+)-Ergothioneine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America L-(+)-Ergothioneine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa L-(+)-Ergothioneine Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 62. Middle East and Africa L-(+)-Ergothioneine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa L-(+)-Ergothioneine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa L-(+)-Ergothioneine Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. L-(+)-Ergothioneine Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. L-(+)-Ergothioneine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Fermentation
  • Enzymatic Synthesis
  • Chemical Synthesis
Applications
  • Dietary Supplements
  • Food & Beverages
  • Cosmetics & Personal Care
  • Pet Nutrition
Companies covered
  • Bloomage Biotech
  • Chuanning Biotechnology
  • Shanghai EGT Synbio
  • GeneIII Biotechnology
  • Readline Biotech
  • SIYOMICRO
  • Abiochem
  • Magic Health
  • Seedling Bio
  • Focusfreda
  • Nutri Force
  • Natural Field
  • GsynBio
  • Hechen Bioworkx
  • Changzhou Kaixing Biotechnology
  • Spec Chem Industry
  • Conagen
  • Mironova Labs
  • NAGASE

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global L-(+)-Ergothioneine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global L-(+)-Ergothioneine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 L-(+)-Ergothioneine Market by Type
  6. 1.3.1 Fermentation
  7. 1.3.2 Enzymatic Synthesis
  8. 1.3.3 Chemical Synthesis
  9. 1.4 Global L-(+)-Ergothioneine Market Size by Type
  10. 1.4.1 Global L-(+)-Ergothioneine Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global L-(+)-Ergothioneine Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global L-(+)-Ergothioneine Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America L-(+)-Ergothioneine Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe L-(+)-Ergothioneine Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific L-(+)-Ergothioneine Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America L-(+)-Ergothioneine Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa L-(+)-Ergothioneine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 L-(+)-Ergothioneine Industry Trends
  2. 2.2 L-(+)-Ergothioneine Industry Drivers
  3. 2.3 L-(+)-Ergothioneine Industry Opportunities and Challenges
  4. 2.4 L-(+)-Ergothioneine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by L-(+)-Ergothioneine Revenue (2021-2026)
  2. 3.2 Global Top Players by L-(+)-Ergothioneine Sales (2021-2026)
  3. 3.3 Global Top Players by L-(+)-Ergothioneine Price (2021-2026)
  4. 3.4 Global L-(+)-Ergothioneine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global L-(+)-Ergothioneine Major Company Production Sites & Headquarters
  6. 3.6 Global L-(+)-Ergothioneine Company, Product Type & Application
  7. 3.7 Global L-(+)-Ergothioneine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global L-(+)-Ergothioneine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 L-(+)-Ergothioneine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 L-(+)-Ergothioneine Tier 1, Tier 2, and Tier 3
4 L-(+)-Ergothioneine Regional Status and Outlook
  1. 4.1 Global L-(+)-Ergothioneine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global L-(+)-Ergothioneine Historic Market Size by Region
  3. 4.2.1 Global L-(+)-Ergothioneine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global L-(+)-Ergothioneine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global L-(+)-Ergothioneine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global L-(+)-Ergothioneine Forecasted Market Size by Region
  7. 4.3.1 Global L-(+)-Ergothioneine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global L-(+)-Ergothioneine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global L-(+)-Ergothioneine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 L-(+)-Ergothioneine by Application
  1. 5.1 L-(+)-Ergothioneine Market by Application
  2. 5.1.1 Dietary Supplements
  3. 5.1.2 Food & Beverages
  4. 5.1.3 Cosmetics & Personal Care
  5. 5.1.4 Pet Nutrition
  6. 5.2 Global L-(+)-Ergothioneine Market Size by Application
  7. 5.2.1 Global L-(+)-Ergothioneine Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global L-(+)-Ergothioneine Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global L-(+)-Ergothioneine Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America L-(+)-Ergothioneine Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe L-(+)-Ergothioneine Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific L-(+)-Ergothioneine Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America L-(+)-Ergothioneine Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa L-(+)-Ergothioneine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Bloomage Biotech
  2. 6.1.1 Bloomage Biotech Company Information
  3. 6.1.2 Bloomage Biotech Business Overview
  4. 6.1.3 Bloomage Biotech L-(+)-Ergothioneine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bloomage Biotech L-(+)-Ergothioneine Product Portfolio
  6. 6.1.5 Bloomage Biotech Recent Developments
  7. 6.2 Chuanning Biotechnology
  8. 6.2.1 Chuanning Biotechnology Company Information
  9. 6.2.2 Chuanning Biotechnology Business Overview
  10. 6.2.3 Chuanning Biotechnology L-(+)-Ergothioneine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Chuanning Biotechnology L-(+)-Ergothioneine Product Portfolio
  12. 6.2.5 Chuanning Biotechnology Recent Developments
  13. 6.3 Shanghai EGT Synbio
  14. 6.3.1 Shanghai EGT Synbio Company Information
  15. 6.3.2 Shanghai EGT Synbio Business Overview
  16. 6.3.3 Shanghai EGT Synbio L-(+)-Ergothioneine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Shanghai EGT Synbio L-(+)-Ergothioneine Product Portfolio
  18. 6.3.5 Shanghai EGT Synbio Recent Developments
  19. 6.4 GeneIII Biotechnology
  20. 6.4.1 GeneIII Biotechnology Company Information
  21. 6.4.2 GeneIII Biotechnology Business Overview
  22. 6.4.3 GeneIII Biotechnology L-(+)-Ergothioneine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 GeneIII Biotechnology L-(+)-Ergothioneine Product Portfolio
  24. 6.4.5 GeneIII Biotechnology Recent Developments
  25. 6.5 Readline Biotech
  26. 6.5.1 Readline Biotech Company Information
  27. 6.5.2 Readline Biotech Business Overview
  28. 6.5.3 Readline Biotech L-(+)-Ergothioneine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Readline Biotech L-(+)-Ergothioneine Product Portfolio
  30. 6.5.5 Readline Biotech Recent Developments
  31. 6.6 SIYOMICRO
  32. 6.6.1 SIYOMICRO Company Information
  33. 6.6.2 SIYOMICRO Business Overview
  34. 6.6.3 SIYOMICRO L-(+)-Ergothioneine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 SIYOMICRO L-(+)-Ergothioneine Product Portfolio
  36. 6.6.5 SIYOMICRO Recent Developments
  37. 6.7 Abiochem
  38. 6.7.1 Abiochem Company Information
  39. 6.7.2 Abiochem Business Overview
  40. 6.7.3 Abiochem L-(+)-Ergothioneine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Abiochem L-(+)-Ergothioneine Product Portfolio
  42. 6.7.5 Abiochem Recent Developments
  43. 6.8 Magic Health
  44. 6.8.1 Magic Health Company Information
  45. 6.8.2 Magic Health Business Overview
  46. 6.8.3 Magic Health L-(+)-Ergothioneine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Magic Health L-(+)-Ergothioneine Product Portfolio
  48. 6.8.5 Magic Health Recent Developments
  49. 6.9 Seedling Bio
  50. 6.9.1 Seedling Bio Company Information
  51. 6.9.2 Seedling Bio Business Overview
  52. 6.9.3 Seedling Bio L-(+)-Ergothioneine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Seedling Bio L-(+)-Ergothioneine Product Portfolio
  54. 6.9.5 Seedling Bio Recent Developments
  55. 6.10 Focusfreda
  56. 6.10.1 Focusfreda Company Information
  57. 6.10.2 Focusfreda Business Overview
  58. 6.10.3 Focusfreda L-(+)-Ergothioneine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Focusfreda L-(+)-Ergothioneine Product Portfolio
  60. 6.10.5 Focusfreda Recent Developments
  61. 6.11 Nutri Force
  62. 6.11.1 Nutri Force Company Information
  63. 6.11.2 Nutri Force Business Overview
  64. 6.11.3 Nutri Force L-(+)-Ergothioneine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Nutri Force L-(+)-Ergothioneine Product Portfolio
  66. 6.11.5 Nutri Force Recent Developments
  67. 6.12 Natural Field
  68. 6.12.1 Natural Field Company Information
  69. 6.12.2 Natural Field Business Overview
  70. 6.12.3 Natural Field L-(+)-Ergothioneine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Natural Field L-(+)-Ergothioneine Product Portfolio
  72. 6.12.5 Natural Field Recent Developments
  73. 6.13 GsynBio
  74. 6.13.1 GsynBio Company Information
  75. 6.13.2 GsynBio Business Overview
  76. 6.13.3 GsynBio L-(+)-Ergothioneine Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 GsynBio L-(+)-Ergothioneine Product Portfolio
  78. 6.13.5 GsynBio Recent Developments
  79. 6.14 Hechen Bioworkx
  80. 6.14.1 Hechen Bioworkx Company Information
  81. 6.14.2 Hechen Bioworkx Business Overview
  82. 6.14.3 Hechen Bioworkx L-(+)-Ergothioneine Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Hechen Bioworkx L-(+)-Ergothioneine Product Portfolio
  84. 6.14.5 Hechen Bioworkx Recent Developments
  85. 6.15 Changzhou Kaixing Biotechnology
  86. 6.15.1 Changzhou Kaixing Biotechnology Company Information
  87. 6.15.2 Changzhou Kaixing Biotechnology Business Overview
  88. 6.15.3 Changzhou Kaixing Biotechnology L-(+)-Ergothioneine Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Changzhou Kaixing Biotechnology L-(+)-Ergothioneine Product Portfolio
  90. 6.15.5 Changzhou Kaixing Biotechnology Recent Developments
  91. 6.16 Spec Chem Industry
  92. 6.16.1 Spec Chem Industry Company Information
  93. 6.16.2 Spec Chem Industry Business Overview
  94. 6.16.3 Spec Chem Industry L-(+)-Ergothioneine Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Spec Chem Industry L-(+)-Ergothioneine Product Portfolio
  96. 6.16.5 Spec Chem Industry Recent Developments
  97. 6.17 Conagen
  98. 6.17.1 Conagen Company Information
  99. 6.17.2 Conagen Business Overview
  100. 6.17.3 Conagen L-(+)-Ergothioneine Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Conagen L-(+)-Ergothioneine Product Portfolio
  102. 6.17.5 Conagen Recent Developments
  103. 6.18 Mironova Labs
  104. 6.18.1 Mironova Labs Company Information
  105. 6.18.2 Mironova Labs Business Overview
  106. 6.18.3 Mironova Labs L-(+)-Ergothioneine Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Mironova Labs L-(+)-Ergothioneine Product Portfolio
  108. 6.18.5 Mironova Labs Recent Developments
  109. 6.19 NAGASE
  110. 6.19.1 NAGASE Company Information
  111. 6.19.2 NAGASE Business Overview
  112. 6.19.3 NAGASE L-(+)-Ergothioneine Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 NAGASE L-(+)-Ergothioneine Product Portfolio
  114. 6.19.5 NAGASE Recent Developments
7 North America by Country
  1. 7.1 North America L-(+)-Ergothioneine Sales by Country
  2. 7.1.1 North America L-(+)-Ergothioneine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America L-(+)-Ergothioneine Sales by Country (2021-2026)
  4. 7.1.3 North America L-(+)-Ergothioneine Sales Forecast by Country (2027-2032)
  5. 7.2 North America L-(+)-Ergothioneine Market Size by Country
  6. 7.2.1 North America L-(+)-Ergothioneine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America L-(+)-Ergothioneine Market Size by Country (2021-2026)
  8. 7.2.3 North America L-(+)-Ergothioneine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe L-(+)-Ergothioneine Sales by Country
  2. 8.1.1 Europe L-(+)-Ergothioneine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe L-(+)-Ergothioneine Sales by Country (2021-2026)
  4. 8.1.3 Europe L-(+)-Ergothioneine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe L-(+)-Ergothioneine Market Size by Country
  6. 8.2.1 Europe L-(+)-Ergothioneine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe L-(+)-Ergothioneine Market Size by Country (2021-2026)
  8. 8.2.3 Europe L-(+)-Ergothioneine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific L-(+)-Ergothioneine Sales by Country
  2. 9.1.1 Asia-Pacific L-(+)-Ergothioneine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific L-(+)-Ergothioneine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific L-(+)-Ergothioneine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific L-(+)-Ergothioneine Market Size by Country
  6. 9.2.1 Asia-Pacific L-(+)-Ergothioneine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific L-(+)-Ergothioneine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific L-(+)-Ergothioneine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America L-(+)-Ergothioneine Sales by Country
  2. 10.1.1 South America L-(+)-Ergothioneine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America L-(+)-Ergothioneine Sales by Country (2021-2026)
  4. 10.1.3 South America L-(+)-Ergothioneine Sales Forecast by Country (2027-2032)
  5. 10.2 South America L-(+)-Ergothioneine Market Size by Country
  6. 10.2.1 South America L-(+)-Ergothioneine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America L-(+)-Ergothioneine Market Size by Country (2021-2026)
  8. 10.2.3 South America L-(+)-Ergothioneine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa L-(+)-Ergothioneine Sales by Country
  2. 11.1.1 Middle East and Africa L-(+)-Ergothioneine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa L-(+)-Ergothioneine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa L-(+)-Ergothioneine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa L-(+)-Ergothioneine Market Size by Country
  6. 11.2.1 Middle East and Africa L-(+)-Ergothioneine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa L-(+)-Ergothioneine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa L-(+)-Ergothioneine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 L-(+)-Ergothioneine Value Chain Analysis
  2. 12.1.1 L-(+)-Ergothioneine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 L-(+)-Ergothioneine Production Mode & Process
  7. 12.2 L-(+)-Ergothioneine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 L-(+)-Ergothioneine Distributors
  10. 12.2.3 L-(+)-Ergothioneine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst